|
Atlanta 2001/01/31 -While reiterating the advice that two screening tests for colorectal
cancer--the fecal occult blood test and flexible sigmoidoscopy--are better
indicators of the presence of disease when taken together than either one alone,
the American Cancer Society (ACS) acknowledges in its latest guidelines update
that screening for colorectal cancer with either test alone is far better than
not being screened at all.
Writing in the January/February 2001 issue of CA, Robert Smith, PhD,
ACS Director of Screening, and colleagues report that despite ample evidence
showing the effectiveness of colorectal cancer screening, as well as excellent
survival rates when the disease is detected and treated early, compliance with
previous screening guidelines by both U.S. adults and health care providers has
been poor. The conclusion reached by an ACS colorectal cancer advisory group
was, therefore, to modify previous guidelines in an effort to encourage
appropriate use of any colorectal screening technique.
The authors note, "Of primary importance at this time is that clinicians
recommend at least one of the appropriate screening options for all of their
eligible patients. Evidence demonstrates that when a screening recommendation
comes directly from the clinician, compliance with colorectal cancer screening
can be quite high."
The article also covers other techniques for early detection of colorectal
cancer, such as colonoscopy, which is considered the "gold standard," and double
contrast barium enema, and provides updated guidelines on screening for prostate
and endometrial cancers, as well as a narrative about early lung cancer
detection.
The January/February issue of CA, which launches a new look and size
for the journal, also features the ACS’s popular annual cancer statistics
report.
CA--A Cancer Journal for Clinicians, published for the American Cancer
Society by Lippincott Williams & Wilkins, is the most widely circulated
cancer journal in the world. It appears six times a year and publishes articles,
usually of a review nature, on all aspects of cancer detection, diagnosis,
treatment, and prevention.
For an interview with any of the authors or an American Cancer Society
authority on any of these or other topics, please contact Joann Schellenbach at
212-382-2169.
P.S. The CA Web site can be accessed via the newly redesigned American
Cancer Society Web site, www.cancer.org,
where it will continue to feature free, full-text versions of all articles that
have been published since 1996.
The American Cancer Society is the nationwide community-based voluntary
health organization dedicated to eliminating cancer as a major health problem by
preventing cancer, saving lives, and diminishing suffering from cancer through
research, education, advocacy, and service.
Lippincott Williams & Wilkins, Inc., is a global publisher of medical,
nursing, and allied health information resources in book, journal, looseleaf,
and electronic media formats. The company is a unit of Wolters Kluwer
International Health & Science, a group of leading publishing companies
offering specialized publications and software in medicine, nursing, pharmacy,
science, and related areas.
Joann Schellenbach
National Director Media Relations
American Cancer Society
212-382-2169
jschelle@cancer.org
|